Filing Flows › Core Laboratories (CLB) › Operating margin
Core Laboratories (CLB) operating margin by quarter
Core Laboratories' operating margin was 9.1% in Q3 2026 (third quarter 2026), +1.8 pts from Q2 2026. Over the last 6 quarters it ranged from 3.6% (Q1 2025) to 15.6% (Q3 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 9.1% | +1.8 pts | -6.4 pts |
| Q2 2026 | 7.3% | -4.1 pts | -4.4 pts |
| Q4 2025 | 11.5% | -4.1 pts | — |
| Q3 2025 | 15.6% | +3.8 pts | — |
| Q2 2025 | 11.7% | +8.2 pts | — |
| Q1 2025 | 3.6% | — | — |
Q3 2026 at a glance
Core Laboratories, Q3 2026: revenue $132M (-2% year over year), operating margin 9.1%, net earnings $5.4M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Core Laboratories' operating margin?
Core Laboratories' operating margin was 9.1% in Q3 2026 (third quarter 2026), +1.8 pts from Q2 2026.
How has Core Laboratories' operating margin changed?
Over the last 6 quarters it ranged from 3.6% (Q1 2025) to 15.6% (Q3 2025).